It has been demonstrated that completemolecular remission in follicularlymphoma is associatedwith an improved outcome. Therefore,the object of modern therapyfor indolent lymphoma should be toachieve this goal.
Angelo Michele Carella, MD
Advertisement
Articles by Angelo Michele Carella, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
ASCO 2026: The Presentations That May Shape The Future of Multiple Myeloma
2
What Are The Top Lymphoma Abstracts at ASCO 2026?
3
ASCO 2026: Key Genitourinary Oncology Trials to Watch For
4
Durvalumab Plus BCG Earns FDA Approval For High-Risk NMIBC
5